Connect with us

Headlines

Ocular Technologies Changes Hands for $40M+

mm

Published

on

The deal is expected to close this year.

Private equity firm Auven Therapeutics is selling portfolio company Ocular Technologies Sarl to India-based Sun Pharmaceutical Industries.

Ocular Technologies holds the rights to Seciera, a drug being developed for the treatment of dry eye disease. Seciera is currently being evaluated in a Phase 3 trial.

In the transaction, Auven will receive an upfront payment of $40 million plus “substantial contingent development and sales milestones.” Auven will also receive tiered royalties on global sales of Seciera.

“We believe that the Sun Pharma team has the ophthalmology expertise, the corporate focus and the commercial resources to launch Seciera aggressively in the U.S. and major global markets,” said Stephen Evans-Freke, co-founder and managing general partner of Auven Therapeutics. “We are confident Sun will optimize Seciera’s impact on a large, rapidly growing disease indication that is clearly underserved by currently available treatment options.”

Advertisement

Jerry Peter, vice-president and head of Sun Ophthalmics, said his unit hopes to “bring Seciera to ophthalmologists and optometrists globally, the market for which is estimated to touch $5 billion worldwide by 2020,” the Business Standard reports.

The deal is expected to close before the end of 2016.

Read the press release

Read more at the Business Standard

Advertisement

SPONSORED VIDEO

SPONSORED BY VARILUX

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular